Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
更正:一项使用抗Aβ原纤维抗体lecanemab治疗早期阿尔茨海默病的随机、双盲、2b期概念验证临床试验
期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-022-00995-9
Swanson, Chad J; Zhang, Yong; Dhadda, Shobha; Wang, Jinping; Kaplow, June; Lai, Robert Y K; Lannfelt, Lars; Bradley, Heather; Rabe, Martin; Koyama, Akihiko; Reyderman, Larisa; Berry, Donald A; Berry, Scott; Gordon, Robert; Kramer, Lynn D; Cummings, Jeffrey L